Source: CFN Media Group

Hyasynth Bio: Hyasynth first to market with CBD in global race to commercialize cannabinoids produced using microbial biosynthesis

MONTREAL, Sept. 28, 2020 /CNW Telbec/ - Hyasynth, a sustainable biotechnology company, takes top spot from global competitors by making the first ever sale of cannabidiol (CBD) produced and extracted from yeast. Hyasynth produces CBD through a yeast fermentation process, without the need for traditional cultivation and extraction from cannabis or hemp plants. The material was produced [...]The post Hyasynth first to market with CBD in global race to commercialize cannabinoids produced using microbial biosynthesis appeared first on CannabisFN.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Kevin Chen's photo - Co-Founder & CEO of Hyasynth Bio

Co-Founder & CEO

Kevin Chen

CEO Approval Rating

76/100

Read more